超声引导下微波消融、手术切除治疗肝癌的临床效果及安全性研究  

Ultrasound-guided Percutaneous Microwave Ablation and Surgical Resection in the Treatment of Liver Cancer,Efficacy,and Safety Research

作　　者：庞武[1] 陈莉红[1] 戴毅[1] 朱宇[1] 葛明刚[1] 肖昌武[1] 

机构地区：[1]四川省遂宁市中心医院肝胆外科,遂宁629000

出　　处：《中国医药导刊》2017年第5期458-459,共2页Chinese Journal of Medicinal Guide

摘　　要：目的:探索超声引导下微波消融、手术切除治疗肝癌的临床效果及安全性。方法:选取2015年6月~2016年6月我院收治的100例肝癌患者,将患者动态随机化分为两组,两组患者各有50例,对照组和观察组分别采用手术切除治疗和超声引导下微波消融治疗。结果:观察组患者并发症发生率(2.00%)、ALB(35.94±4.05)g/L、TB(21.58±4.05)μmol/L、ALT(146.58±15.69)IU/L、AST(165.47±24.95)IU/L、生存率(98.00%)、复发率(2.00%)均优于对照组患者(P<0.05)。结论:超声引导下微波消融治疗肝癌患者效果更为显著,且安全性较高。Objective：Explore ultrasound-guided percutaneous microwave ablation and surgical removal of the clinical effect and safety for the treatment of liver cancer.Methods：Selection during June 2015 to June 2016,our hospital 100 cases of liver cancer patients,the patients with dynamic classified as two groups at random,with 50 cases in both groups,control group and observation group were treated by surgical resection and ultrasound-guided percutaneous microwave ablation therapy.Results：Observation group of patients with complication rate（2.00%）,ALB （35.94 ＆#177; 4.05） g/L,TB （21.58 ＆#177; 4.05） μmol/L,ALT （146.58 ＆#177; 15.69） IU/L,AST（165.47 ＆#177; 24.95） IU/L,survival rate （98.00%）,recurrence rate （2.00%） were bcttcr than the control group （P 〈 0.05） in patients with.Conclusion：Ultrasound guided by a more significant effect of microwave ablation treatment for liver cancer patients,and higher security.

关 键 词：超声引导下微波消融 手术切除 肝癌 

分 类 号：R735.7[医药卫生—肿瘤]